Home > Products > HER2 & VEGF
> Anti-HER2 x Anti-VEGF Bispecific Antibody (IgG-IgG)
Anti-HER2 x Anti-VEGF Bispecific Antibody (IgG-IgG) (CAT#: BSIG-168)
Anti-HER2 x Anti-VEGF Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-HER2 and anti-VEGF parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind two factors simultaneously and inhibit cell proliferation. It is designed for the research of Colorectal cancer; Breast cancer; Lung cancer; Renal cell cancer (RCC); Glioma cancer; Glioblastoma; Ovarian cancer therapy.
There are currently no customer reviews or questions for Anti-HER2 x Anti-VEGF Bispecific Antibody (IgG-IgG) (BSIG-168). Click the button below to contact us or submit your feedback about this product.